During a live event, Sumanta K. Pal and other oncologists discuss the safety and efficacy of belzutifan for advanced renal ...

The study leads with a statistic as striking as Soerjomataram's opening claim: 7.1 million new cases of cancer were linked to what's known as modifiable risk factors (MRFs) — such as consuming tobacco ...

Overview AI tools analyse patient data to anticipate pain, distress, and symptom escalation well before the situation worsens.Machine learning supports tailored ...

Nearly 40% of new cancer cases worldwide are potentially preventable, according to one of the first investigations 1 of its ...

Euthanasia protocols rely on off-label drugs. With little data and no oversight on complications, how do we know the death is ...

Approximately four in 10 cancer cases worldwide may be preventable, according to a new report.An estimated 7.1 million of the 18.7 million global cancer diagnoses in 2022 — equating to 37.9% — could ...

Up to four in ten cancer cases worldwide could be prevented, according to a new global analysis from the World Health Organization (WHO) and its ...

The FDA approved Scancell's phase 3 trial of iSCIB1+ for advanced melanoma, focusing on progression-free survival as a ...

Natco Pharma receives USFDA approval for Erdafitinib, a generic cancer drug for advanced urothelial carcinoma patients.

Metastasis-directed therapy (MDT) significantly improved outcomes in patients with oligometastatic prostate cancer, according ...